BioCentury
ARTICLE | Company News

Hyal deal

July 11, 1994 7:00 AM UTC

Hyal Pharmaceutical Corp. (HYALF) Ciba-Geigy Canada Ltd. exercised a six-month option to exclusively evaluate and license HYALF's pain product, HYAL-AT2101, for Canada. HYAL-AT2101 is a topical formu...